SEC Form 4/A · accession 0001177648-16-000018
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Paul J Mellett
Officer — Treasurer and CFO
Period of report
Feb 26, 2016
Accepted (ET)
Nov 22, 2016 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 26, 2016 | M | 6,689 | $1.293 | A | 61,086 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.293 | Feb 26, 2016 | M | 6,689 | D | — | Jun 23, 2016 | Common Stock | 6,689 | 0 | D |
Explanation of responses
- F1100% of the shares subject to the option are fully vested and exercisable.
- F2This amendment is being filed to correct the original Form 4 filing by amending the number of securities beneficially owned following the reported transaction from "67,086" to "61,086". This amendment corrects an administrative error.